News

Johnson & Johnson’s Rare AAA Rating No Longer at Risk, S&P Says
Johnson & Johnson, one of the few remaining companies with a top credit rating, is no longer at risk of a downgrade, S&P ...
Johnson & Johnson (JNJ): Among the Best Long-Term Dividend Stocks to Buy According to Billionaires
We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we ...
J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports
HistoSonics, a medical technology company backed by Johnson & Johnson , is exploring a potential sale at a valuation of more than $2.5 billion after receiving multiple takeover offers, the Financial ...
Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months?
We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a ...
Johnson & Johnson Pivots Its AI Strategy
The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...
Johnson & Johnson Just Proved The Bears Wrong Again
Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...
The Washington Post9d
‘No More Tears’ exposes a company, and industry, imperiling consumers
A product that was assumed to be benign turns out to be dangerous. A heavily marketed new drug has serious side effects. A medical device leaves a trail of complications. In all of these scenarios ...